A comprehensive view of Injectables / Infusions / IV Drips. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer reports its experimental injectable hemophilia drug marstacimab reduced bleeding frequency without safety concerns in Phase 3 study; marstacimab works by shutting down a protein that impedes blood clotting

FDA approves Brixadi buprenorphine for extended-release subcutaneous use in treating opioid use disorder; Brixadi approved for weekly and monthly subcutaneous injectable formulations at varying doses

Innoviva's Xacduro gains FDA approval to treat hospital-acquired and ventilator-associated bacterial pneumonia caused by Acinetobacter baumannii-calcoaceticus complex; WHO reports Acinetobacter is the highest-risk bacterial pathogen for human health

Peer-reviewed study finds Pfizer's danuglipron oral weight loss drug proves as effective as Novo Nordisk's Ozempic injection in clinical trial; Pfizer drug offers a potentially more convenient treatment option: JAMA Network

Grunenthal's injectable Resiniferatoxin gets breakthrough therapy designation from FDA for knee osteoarthritis pain; knee osteoarthritis is a progressive condition affecting over 360 million people worldwide

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count